Identifying the chemical switches that turn different parts of our immune system on and off is opening up new avenues for treating diseases such as Parkinson’s, Alzheimer’s, cancer and rheumatoid arthritis – and potential new uses for discarded drugs, according to Professor Luke O’Neill, an immunologist at Trinity College Dublin, Ireland. Professor O'Neill's research has been part-funded by European Research Council funding.
Read more here
8 days ago - Getting Business Brexit Ready
25 days ago - Customs Workshops for businesses
71 days ago - TCD leads EU-funded project into immune system switches
27/03/2019 - Brexit and Managing the Working Capital Challenge - Webinar .
09/04/2019 - B2B Matchmaking Event at Ocean Business 2019 .